21st Jan 2005 12:00
21 January 2005Shire Pharmaceuticals Group plc (the "Company")Application has been made to the London Stock Exchange and the UK ListingAuthority for the block listing of 2,500,000 ordinary shares of 5 pence eachfully paid in the Company. The shares may be issued pursuant to obligationsthat may arise under the Shire Pharmaceuticals Group plc "B" Executive ShareOption Scheme.T MayCompany SecretaryFor further information please contact:Investor Relations Clĩa Rosenfeld +44 1256 894 160 Notes to editorsShire Pharmaceuticals Group plcShire Pharmaceuticals Group plc (Shire) is a global specialty pharmaceuticalcompany with a strategic focus on meeting the needs of the specialist physicianand currently focuses on developing projects and marketing products in theareas of central nervous system (CNS), gastrointestinal (GI), and renaldiseases. Shire has operations in the world's key pharmaceutical markets (US,Canada, UK, France, Italy, Spain and Germany) as well as a specialist drugdelivery unit in the US.For further information on Shire, please visit the Company's website: www.shire.com.ENDRelated Shares:
Shire